Journal article
A. Vilgelm, A. Richmond
Front. Immunol., 2019
Front. Immunol., 2019
Semantic Scholar
DOI
PubMedCentral
PubMed
Cite
Cite
APA
Click to copy
Vilgelm, A., & Richmond, A. (2019). Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy. Front. Immunol.
Chicago/Turabian
Click to copy
Vilgelm, A., and A. Richmond. “Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy.” Front. Immunol. (2019).
MLA
Click to copy
Vilgelm, A., and A. Richmond. “Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy.” Front. Immunol., 2019.
BibTeX Click to copy
@article{a2019a,
title = {Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy},
year = {2019},
journal = {Front. Immunol.},
author = {Vilgelm, A. and Richmond, A.}
}
Abstract
Chemokines are small secreted proteins that orchestrate migration and positioning of immune cells within the tissues. Chemokines are essential for the function of the immune system. Accumulating evidence suggest that chemokines play important roles in tumor microenvironment. In this review we discuss an association of chemokine expression and activity within the tumor microenvironment with cancer outcome. We summarize regulation of immune cell recruitment into the tumor by chemokine-chemokine receptor interactions and describe evidence implicating chemokines in promotion of the “inflamed” immune-cell enriched tumor microenvironment. We review both tumor-promoting function of chemokines, such as regulation of tumor metastasis, and beneficial chemokine roles, including stimulation of anti-tumor immunity and response to immunotherapy. Finally, we discuss the therapeutic strategies target tumor-promoting chemokines or induce/deliver beneficial chemokines within the tumor focusing on pre-clinical studies and clinical trials going forward. The goal of this review is to provide insight into comprehensive role of chemokines and their receptors in tumor pathobiology and treatment.
